Immunophenotyping

Welcome!

We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of six providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Birgit Fogal at Boehringer Ingelheim. Please review the learning objectives below for more information on what you will learn in this lecture.
 
If you are new to HESI and would like to learn more about our organization, please take a moment to visit our website at https://hesiglobal.org.

Target Audience

This course is intended for the science professional or graduate student looking to learn the fundamental science and key considerations that are examined in immune safety assessment. The advanced topics offered in this module are intended to take a deeper dive into specific scientific areas. These courses are recommended for the more experienced scientist with a firm grasp of the information highlighted in the introduction module.

Learning Objectives

 
The learner will have an:
 
  • understanding what immunophenotyping is and what it can be used for.
  • understanding of basic flow Cytometry, the technology used for IP (and what quality parameters/pitfalls to look for).
  • understanding of basic IP markers in different tissues and species, how these compare to humans.
  • an understood basic interpretation of IP data (as well as challenges, pitfalls and potential follow ups). 
  • an idea on additional more specific readouts that can be added to the basic parameters to answer additional questions. 

Additional Information

AttachmentSize
PDF icon Immunophenotyping slide deck - Fogal3.39 MB
Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
03/22/2022
Course expires: 
03/31/2027
Cost:
$35.00
Rating: 
0

Lectures in this module

 
Clinical pathology in preclinical immuno-safety assessment
 
Immunopathology: Evaluation from Discovery to Safety Assessment
 
TDAR assessments
 
Cytokine Release Syndrome (CRS)
 
Immunophenotyping
 
Systems biology applied to immune safety
Birgit Fogal, Ph.D.
Boehringer Ingelheim

Available Credit

  • 1.00 Participation

Price

Cost:
$35.00
Please login or register to take this course.

Required Hardware/software

This platform, Ethos CE, works with most modern web browsers (e.g., Chrome, Internet Explorer, MS Edge, Safari). Contact itc@hesiglobal.org if you are having any difficulties with this platform.